Summary of Purpose
To determine how long blood transfusions are needed for primary stroke prevention. Also, to determine the duration of risk associated with abnormal transcranial Doppler ultrasound (TCD) and to determine the specificity of the stroke risk model developed in STOP 1 in patients with abnormal TCD measurements.Read More →
The following dates are available for this trial. Trial information last updated on 17 February 2016.
|1 Jul 2000||21 Aug 2000||Unavailable||1 Feb 2006||1 Oct 2005||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Allocation: Randomized
- Purpose: Prevention
Donald Brambilla, PhD New England Research Institutes Watertown, Massachusettsrjadams@mail.mcg.edu